$63.99
Currently 35 wall-street analysts regularly analyze the financials of Crispr Therapeutics Ag on a frequent basis to provide recommendations along with target share price. 35 analysts offering 12-month price forecasts for Crispr Therapeutics Ag (CRSP) have a share price target of $82.95. This median of share price forecast represents a 29.64% upside from the latest price of $63.99 as on 04.11.25.
As per the chart shown above, analysts believe that the Crispr Therapeutics Ag (CRSP) share price will touch around $82.95 in next 12-months.
Below is a chart showing the percentage difference between Crispr Therapeutics Ag's share price and its median forecast price. As on 04.11.25, the difference is -20.25%
Based on 35 analysts tracking and researching Crispr Therapeutics Ag (CRSP) share have hold recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 11 | 11 | 11 |
| Outperform | 8 | 8 | 8 |
| Hold | 12 | 13 | 13 |
| Underperform | 0 | 0 | 0 |
| Sell | 3 | 3 | 3 |